State Health Society Bihar, under National Rural Health Mission, invites application from suitable candidates for the following post on contractual basis for district hospitals under NPCDCS Programme.
Name of the Post and Number of Vacancies
- District Medical Officer: 6 vacancies
- Medical Oncologist: 6 vacancies
- Cyto-pathologist: 6 vacancies
- Cytopathology Technician: 6 vacancies
- Physiotherapist: 6 vacancies
- Staff Nurse: 24 vacancies
- Counsellor: 6 vacancies
- Data Entry Operator: 6 vacancies
- Care Co-ordinator: 6 vacancies
Important Dates
Last date for sending application: 21 February 2012 till 5 pm
Age Limit (as on 1 January 2012)
- District Medical Officer, Medical Oncologist, and Cyto-pathologist: Maximum 50 years
- Cytopathology Technician, Physiotherapist, Staff Nurse, Counsellor: Maximum 40 years
- Data Entry Operator and Care Co-ordinator: Maximum 30 years
Consolidated Salary
- District Medical Officer: Rs 55000
- Medical Oncologist: Rs 55000
- Cyto-pathologist: Rs 55000
- Cytopathology Technician: Rs 20000
- Physiotherapist: Rs 20000
- Staff Nurse: Rs 20000
- Counsellor: Rs 12000
- Data Entry Operator: Rs 10000
- Care Co-ordinator: Rs 6000
Application Fee: Application fee for General category candidate is Rs 500, BC/ EC category candidate is Rs 300 and fee for SC and ST category candidate is Rs 250. The fee needs to be paid in the form of Demand Draft drawn on any payable at Patna favouring ‘State Health Society, Bihar'.
Selection Procedure: The candidates will be selected on basis of Interview.
How to Apply: Application in the prescribed format and complete in all respect must be sent to Executive Director, State Health Society, Bihar, Pariwar Kalyan Bhawan, Sheikhpura, Patna-800014 containing bank draft, self attested photocopies of certificate and testimonials in sealed envelope only through speed/ registered post so as to reach the above address before the last date. Name of the post applied for must be mentioned on the top of the envelope.
For more details, please CLICK HERE
Comments
All Comments (0)
Join the conversation